Transaction Data Systems, parent company of Rx30 and Computer-Rx pharmacy software, announced yesterday that it has named Monty Rogers as its new chief strategy officer and chief pharmacist.
Rogers, a seasoned pharmacy professional, leads the company's corporate strategy. The company says that he was selected to join its leadership team because his unique viewpoint allows him to maintain the company's focus on developing market-leading solutions and strategies for the independent and community pharmacy. He brings more than 25 years of industry experience and his personal experience as a pharmacist, to the business. He most recently served as the founder and president of Pharm Assess Inc.
Rogers, said, 'I am excited to take on this role and have already witnessed the commitment by TDS to drive change and provide industry-leading solutions to ensure the pharmacist remains relevant in this continuously evolving healthcare market. I remain a pharmacist with an entrepreneurial spirit and am focused on leading the strategy of our company to ensure independent community pharmacies can impact and drive healthy outcomes for their communities and businesses.'
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business